Bio Green Med Solution Inc (BGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,445 | -7,830 | -7,288 | -7,470 | -11,791 |
| Depreciation Amortization | 20 | 20 | 29 | 32 | 133 |
| Other Working Capital | 61 | -2,065 | 227 | -308 | 809 |
| Other Operating Activity | 430 | 428 | 331 | 266 | 770 |
| Operating Cash Flow | $-7,934 | $-9,447 | $-6,701 | $-7,480 | $-10,079 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -96 | 28 | -39 | -13 | 9 |
| Investing Cash Flow | $-96 | $28 | $-39 | $-13 | $9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,705 | N/A | 630 | 14,949 | 6,794 |
| Dividend Paid | -201 | -201 | -201 | -201 | -200 |
| Other Financing Activity | 0 | 4,049 | 0 | 0 | 0 |
| Financing Cash Flow | $29,504 | $3,848 | $429 | $14,748 | $6,594 |
| Exchange Rate Effect | 47 | -48 | -95 | 135 | -444 |
| Beginning Cash Position | 11,885 | 17,504 | 23,910 | 16,520 | 20,440 |
| End Cash Position | 33,406 | 11,885 | 17,504 | 23,910 | 16,520 |
| Net Cash Flow | $21,521 | $-5,619 | $-6,406 | $7,390 | $-3,920 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,934 | -9,447 | -6,701 | -7,480 | -10,079 |
| Capital Expenditure | -96 | -10 | -39 | -13 | -3 |
| Free Cash Flow | -8,030 | -9,457 | -6,740 | -7,493 | -10,082 |